ST Pharm Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
4,294
2,443
11,804
115,196
132,301
Total Accounts Receivable
18,729
19,212
16,636
17,968
31,692
Inventories
29,870
34,961
58,710
91,371
57,975
Other Current Assets
1,571
155
8,630
340
6,224
Total Current Assets
54,465
56,771
95,779
224,875
228,192
Net Property, Plant & Equipment
45,038
63,759
134,099
138,430
151,580
Total Investments and Advances
12,583
19,562
652
1,037
471
Intangible Assets
939
829
1,092
1,080
1,211
Other Assets
-
-
-
865
1,300
Total Assets
115,806
147,097
236,894
371,366
385,212
ST Debt & Current Portion LT Debt
48,133
71,168
48,975
1,383
20
Accounts Payable
5,060
4,200
10,862
13,689
3,111
Income Tax Payable
2,575
-
10,687
14,126
7,156
Other Current Liabilities
4,549
7,079
37,704
22,275
18,472
Total Current Liabilities
60,318
82,447
108,227
51,473
28,758
Long-Term Debt
195
176
10,156
137
117
Provision for Risks & Charges
868
1,593
2,200
1,791
309
Deferred Taxes
2,782
1,452
745
1,492
1,129
Total Liabilities
61,381
88,939
125,110
56,988
32,772
Common Equity (Total)
53,707
57,180
110,874
313,245
351,083
Total Shareholders' Equity
53,707
57,180
110,874
313,245
351,083
Total Equity
53,707
57,180
110,874
313,245
351,083
Liabilities & Shareholders' Equity
115,806
147,097
236,894
371,366
385,212
Non-Equity Reserves
718
978
910
1,133
1,357

About ST Pharm Co.

View Profile
Address
#802, Siheunggongdan 1-Na
Siheung-si GY 15086
Korea, Republic Of
Employees -
Website http://www.stpharm.co.kr
Updated 09/14/2018
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation.